EAM Global Investors’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q2 | – | Sell |
-5,177
| Closed | -$747K | – | 159 |
|
2020
Q1 | $747K | Buy |
5,177
+652
| +14% | +$94.1K | 0.44% | 93 |
|
2019
Q4 | $925K | Sell |
4,525
-7,302
| -62% | -$1.49M | 0.37% | 108 |
|
2019
Q3 | $950K | Sell |
11,827
-10,030
| -46% | -$806K | 0.46% | 99 |
|
2019
Q2 | $2.06M | Sell |
21,857
-5,198
| -19% | -$490K | 0.88% | 32 |
|
2019
Q1 | $2.31M | Buy |
27,055
+3,488
| +15% | +$298K | 1.02% | 19 |
|
2018
Q4 | $1.32M | Sell |
23,567
-3,954
| -14% | -$222K | 0.72% | 71 |
|
2018
Q3 | $2.25M | Buy |
+27,521
| New | +$2.25M | 0.91% | 19 |
|